Matsubara et al. [60] reported that fasting plasma GLP-1 levels are significantly lower in CAD patients than in non-CAD patients (3.1 [2.4–3.6] versus 4.0 [3.1–5.9] pM, P < 0.001). The gene discussed is GLP1R; the disease is coronary artery disorder.